Concepedia

Author

Costanza Bogani

University of Florence

Also Known As

C Bogani, C. BOGANI, C. Bogani, Costanza Bogani, L Pieri

51

Publications

2.2K

Citations

21

H-Index

40

Concepts

All Affiliations

University of FlorenceAzienda Ospedaliero-Universitaria CareggiUniversity of Modena and Reggio EmiliaInsermUniversity of Illinois Chicago
CB

About

Costanza Bogani is an author at University of Florence specializing in medicine, hematology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

305

2

Engineering

2

2

56

3

Health Sciences

1

1

15

4

Public Health

1

1

355

5

Biochemistry

1

1

60

Costanza Bogani

×

22

Publications

1.8K

Citations

17

H-Index

YearCitations

Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden

Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli,

Leukemia

2007

355

Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia

Elisabetta Antonioli, Paola Guglielmelli, G Poli,

Haematologica

2007

157

Co‐targeting the PI3K/ <scp>mTOR</scp> and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms

Niccolò Bartalucci, Lorenzo Tozzi, Costanza Bogani,

Journal of Cellular and Molecular Medicine

2013

136

miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis

Ruggiero Norfo, Roberta Zini, Valentina Pennucci,

Blood

2014

123

Molecular Profiling of CD34+ Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (<i>WT1</i>)

Paola Guglielmelli, Roberta Zini, Costanza Bogani,

Stem Cells

2006

120

Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome–Negative Myeloproliferative Neoplasms

Alessandro M. Vannucchi, Giovanna Masala, Elisabetta Antonioli,

Cancer Epidemiology Biomarkers & Prevention

2009

111

mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms

Costanza Bogani, Niccolò Bartalucci, Serena Martinelli,

PLoS ONE

2013

105

Hypermethylation of<i>CXCR4</i>Promoter in CD34+ Cells from Patients with Primary Myelofibrosis

Costanza Bogani, Vanessa Ponziani, Paola Guglielmelli,

Stem Cells

2008

91

A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis

Alessandro M. Vannucchi, Alessandro Pancrazzi, Costanza Bogani,

Leukemia

2006

78

MicroRNA expression profile in granulocytes from primary myelofibrosis patients

Paola Guglielmelli, Lorenzo Tozzi, Alessandro Pancrazzi,

Experimental Hematology

2007

77

Page 1